Search | IOVS | ARVO Journals

Showing 1 – 20 of 20

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

Comparison of imaging area between CLARUS® and Optos®

RIKO OKAMOTO; Osamu Sawada; Yusuke Ichiyama; Shumpei Obata; Masashi Kakinoki; Tomoko Sawada; Yoshitsugu Saishin; Masahito Ohji

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1588.

ARVO Annual Meeting Abstract July 2019

Color abnormality measured with the Rabin cone contrast test in central serous chorioretinopathy.

Saki Murotani; Masashi Kakinoki; Yusuke Ichiyama; Shumpei Obata; Maki Iwasa; Osamu Sawada; Tomoko Sawada; Yoshitsugu Saishin; Masahito Ohji

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1830.

ARVO Annual Meeting Abstract July 2019

Investigation of postoperative refractive error of intraocular lens suturing and intrascreral fixation

Masashi Kakinoki; Osamu Sawada; Yoshitsugu Saishin; Yusuke Ichiyama; Shumpei Obata; Masahito Ohji

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):494.

ARVO Annual Meeting Abstract June 2017

Comparison between wide angle OCT angiography and ultra-wide field fluorescein angiography on the detection of non-perfusion area

Osamu Sawada; Yusuke Ichiyama; Yuka Ito; Masashi Kakinoki; Tomoko Sawada; Yoshitsugu Saishin; Masahito Ohji

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1700.

ARVO Annual Meeting Abstract September 2016

Aqueous vascular endothelial growth factor after bimonthly intravitreal injection of ranibizumab or aflibercept in patients with diabetic macular edema

Osamu Sawada; Yusuke Ichiyama; Yuka Ito; Masato Fujikawa; Masashi Kakinoki; Tomoko Sawada; Yoshitsugu Saishin; Masahito Ohji

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12)

ARVO Annual Meeting Abstract June 2015

Aqueous vascular endothelial growth factor before and after intravitreal injection of bevacizumab or ranibizumab in patients with diabetic macular edema

Osamu Sawada; Masato Fujikawa; Yuka Ito; Tomoko Sawada; Masahito Ohji

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1753.

ARVO Annual Meeting Abstract June 2015

Pneumatic Displacement In Combination With Anti-VEGF Therapy For Subretinal Hemorrhage Secondary To Polypoidal Choroidal Vasculopathy

Masato Fujikawa; Osamu Sawada; Tomoko Sawada; Yoshitsugu Saishin; Hajime Kawamura; Masahito Ohji

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2844.

ARVO Annual Meeting Abstract April 2014

Changes of retinal thickness after vitrectomy for epiretinal membrane with and without internal limiting membrane peeling

Shumpei Obata; Keisuke Iwasaki; Masato Fujikawa; Masashi Kakinoki; Osamu Sawada; Yoshitsugu Saishin; Hajime Kawamura; Masahito Ohji

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1151.

ARVO Annual Meeting Abstract April 2014

Serum and aqueous vascular endothelial growth factor concentration of patients with age-related macular degeneration after intravitreal injection of aflibercept

Xiying Wang; Tomoko Sawada; Osamu Sawada; Yoshitsugu Saishin; Masahito Ohji

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1956.

ARVO Annual Meeting Abstract April 2014

Photoreceptor outer segment length and outer foveal thickness as predictive factors associated with visual outcome after vitrectomy for vitreomacular traction syndrome

Yusuke Ichiyama; Hajime Kawamura; Masato Fujikawa; Osamu Sawada; Yoshitsugu Saishin; Masahito Ohji

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):297.

ARVO Annual Meeting Abstract April 2014

Bimonthly injections of ranibizumab for age-related macular degeneration

Tomoko Sawada; Xiying Wang; Osamu Sawada; Yoshitsugu Saishin; Masahito Ohji

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3944.

ARVO Annual Meeting Abstract June 2013

Molecular events for Bax activation in retinal cell death induced by all-trans-retinal

Osamu Sawada; Akiko Maeda; Shigemi Matsuyama; Tadao Maeda

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):1779.

ARVO Annual Meeting Abstract June 2013

A lack of delayed intraocular pressure elevation after intravitreal injections of ranibizumab for age-related macular degeneration

Yusuke Ichiyama; Tomoko Sawada; Masashi Kakinoki; Osamu Sawada; Yoshitsugu Saishin; Hajime Kawamura; Masahito Ohji

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):6300.

ARVO Annual Meeting Abstract June 2013

QLT091001, a 9-cis-retinal analog, is well tolerated by retinas of mice with impaired visual cycles

Tadao Maeda; Zhiqian Dong; Hui Jin; Osamu Sawada; Songqi Gao; Grazyna Palczewska; Krzysztof Palczewski

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):6362.

Physiology and Pharmacology January 2013

QLT091001, a 9- cis -Retinal Analog, Is Well-Tolerated by Retinas of Mice with Impaired Visual Cycles

PDF

Tadao Maeda; Zhiqian Dong; Hui Jin; Osamu Sawada; Songqi Gao; Deepank Utkhede; Wendy Monk; Grazyna Palczewska; Krzysztof Palczewski
TAGS: mice, retina, retinoids, diagnostic imaging, safety
Invest. Ophthalmol. Vis. Sci.. 2013; 54(1):455-466. https://doi.org/10.1167/iovs.12-11152

Retina August 2012

Effect of Vitrectomy on Aqueous VEGF Concentration and Pharmacokinetics of Bevacizumab in Macaque Monkeys

PDF

Masashi Kakinoki; Osamu Sawada; Tomoko Sawada; Yoshitsugu Saishin; Hajime Kawamura; Masahito Ohji
TAGS: bevacizumab, macaca, mass or substance concentration per volume, pharmacokinetics, vascular endothelial growth factor a, vitrectomy, cercopithecidae, eye, aqueous humor
Invest. Ophthalmol. Vis. Sci.. 2012; 53(9):5877-5880. https://doi.org/10.1167/iovs.12-10164

ARVO Annual Meeting Abstract March 2012

A mouse model of Retinitis Pigmentosa with an E150K mutation in the rod opsin gene

Ning Zhang; Osamu Sawada; Debarshi Mustafi; Tadao Maeda; Krzysztof Palczewski

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):746.

ARVO Annual Meeting Abstract April 2011

The Clearance of Intravitreal Bevacizumab in Vitrectomized Macaque Eyes

Masashi Kakinoki; Taichiro Miyake; Osamu Sawada; Tomoko Sawada; Hajime Kawamura; Masahito Ohji

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):5630.

ARVO Annual Meeting Abstract April 2011

The Minimum Dose of Intravitreal Injection of Bevacizumab Effective againstVascular Endothelial Growth Factor in Macaque Eyes

Taichiro Miyake; Masashi Kakinoki; Osamu Sawada; Tomoko Sawada; Hajime Kawamura; Masahito Ohji

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):5635.

Physiology and Pharmacology March 2010

Pharmacokinetics of Bevacizumab and Its Effect on Vascular Endothelial Growth Factor after Intravitreal Injection of Bevacizumab in Macaque Eyes

PDF

Taichiro Miyake; Osamu Sawada; Masashi Kakinoki; Tomoko Sawada; Hajime Kawamura; Kazumasa Ogasawara; Masahito Ohji
TAGS: bevacizumab, eye, intravitreal injections, macaca, pharmacokinetics, vascular endothelial growth factor a
Invest. Ophthalmol. Vis. Sci.. 2010; 51(3):1606-1608. https://doi.org/10.1167/iovs.09-4140

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Comparison of imaging area between CLARUS® and Optos®

Color abnormality measured with the Rabin cone contrast test in central serous chorioretinopathy.

Investigation of postoperative refractive error of intraocular lens suturing and intrascreral fixation

Comparison between wide angle OCT angiography and ultra-wide field fluorescein angiography on the detection of non-perfusion area

Aqueous vascular endothelial growth factor after bimonthly intravitreal injection of ranibizumab or aflibercept in patients with diabetic macular edema

Aqueous vascular endothelial growth factor before and after intravitreal injection of bevacizumab or ranibizumab in patients with diabetic macular edema

Pneumatic Displacement In Combination With Anti-VEGF Therapy For Subretinal Hemorrhage Secondary To Polypoidal Choroidal Vasculopathy

Changes of retinal thickness after vitrectomy for epiretinal membrane with and without internal limiting membrane peeling

Serum and aqueous vascular endothelial growth factor concentration of patients with age-related macular degeneration after intravitreal injection of aflibercept

Photoreceptor outer segment length and outer foveal thickness as predictive factors associated with visual outcome after vitrectomy for vitreomacular traction syndrome

Bimonthly injections of ranibizumab for age-related macular degeneration

Molecular events for Bax activation in retinal cell death induced by all-trans-retinal

A lack of delayed intraocular pressure elevation after intravitreal injections of ranibizumab for age-related macular degeneration

QLT091001, a 9-cis-retinal analog, is well tolerated by retinas of mice with impaired visual cycles

QLT091001, a 9- cis -Retinal Analog, Is Well-Tolerated by Retinas of Mice with Impaired Visual Cycles

Effect of Vitrectomy on Aqueous VEGF Concentration and Pharmacokinetics of Bevacizumab in Macaque Monkeys

A mouse model of Retinitis Pigmentosa with an E150K mutation in the rod opsin gene

The Clearance of Intravitreal Bevacizumab in Vitrectomized Macaque Eyes

The Minimum Dose of Intravitreal Injection of Bevacizumab Effective againstVascular Endothelial Growth Factor in Macaque Eyes

Pharmacokinetics of Bevacizumab and Its Effect on Vascular Endothelial Growth Factor after Intravitreal Injection of Bevacizumab in Macaque Eyes

To View More...

You must be signed into an individual account to use this feature.